Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Health Canada clears Enbrel for moderately to severely active RA

Dec. 13, 2000

Pyrazole-based antiinflammatory agents patented by Dr. Reddy's team

Dec. 11, 2000

Dimethaid receives approval for Pennsaid lotion in U.K.

Dec. 11, 2000

Integrin alpha4beta1 inhibitors disclosed by AstraZeneca scientists

Nov. 29, 2000

Hydroxamic acid-based MMP inhibitors discovered by Sumitomo team

Nov. 28, 2000

Preparation and use of new MMP/TNF-alpha inhibitors described by Fujisawa

Nov. 28, 2000

Novel cyclic tyrosine kinase inhibitors reported by BMS scientists

Nov. 27, 2000

Phase II/III data, including subgroup analyses, on LJP-394 discussed at ACR meeting

Nov. 24, 2000

Santen presents novel urea TNF-alpha production inhibitors

Nov. 22, 2000

Evidence of biological and clinical activity emerges from phase I/II trial of AnergiX.RA

Nov. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...